The historic rise of Viagra has consistently remained a symbol of pharmaceutical success, however its future within the broader industry now triggers questions about future yields . Alternative versions are undercutting exclusivity , prompting concerns that investing in companies heavily reliant to Viagra's once-dominant influence could be a specul